1995
DOI: 10.1074/jbc.270.33.19383
|View full text |Cite
|
Sign up to set email alerts
|

P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site

Abstract: P-glycoprotein (Pgp or multidrug-resistance protein) shows drug-stimulated ATPase activity. The catalytic sites are known to be of low affinity and specificity for nucleotides. From the sequence, two nucleotide sites are predicted per Pgp molecule. Using plasma membranes from a multidrug-resistant Chinese hamster ovary cell line, which are highly enriched in Pgp, we show that vanadate-induced trapping of nucleotide at a single catalytic site produces stably inhibited Pgp, with t 1/2 for reactivation of ATPase … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

29
431
5
1

Year Published

1998
1998
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 387 publications
(469 citation statements)
references
References 26 publications
29
431
5
1
Order By: Relevance
“…It therefore seems that the conformational changes in the TMDs, at different steps in the catalytic cycle, may have different consequences for the different drug-binding sites for P-gp [68,69], TAP [70] and the histidine permease [71]. For some ABC transporters, the two pockets hydrolyse ATP non-simultaneously, for example, P-gp [22,52,63,72], MutS [36], and the bacterial histidine [50,61] and maltose [73] transporters. Consistent with this, the two nucleotidebinding pockets of a transporter frequently exhibit structural asymmetry even for HisP [29] and HlyB-NBD [40] where the two NBDs are identical in sequence.…”
Section: Stoichiometry Of Atp Binding and Hydrolysismentioning
confidence: 99%
“…It therefore seems that the conformational changes in the TMDs, at different steps in the catalytic cycle, may have different consequences for the different drug-binding sites for P-gp [68,69], TAP [70] and the histidine permease [71]. For some ABC transporters, the two pockets hydrolyse ATP non-simultaneously, for example, P-gp [22,52,63,72], MutS [36], and the bacterial histidine [50,61] and maltose [73] transporters. Consistent with this, the two nucleotidebinding pockets of a transporter frequently exhibit structural asymmetry even for HisP [29] and HlyB-NBD [40] where the two NBDs are identical in sequence.…”
Section: Stoichiometry Of Atp Binding and Hydrolysismentioning
confidence: 99%
“…B, the apparent K m (8-azido-ATP/ADP) for occlusion of nucleotide was determined as described in A above with the following differences. The Pgps were incubated with increasing concentrations of 8-azido-[␣- 32 sis allow the nucleotide diphosphate to be occluded in the presence of Vi (3,18). Vi mimics the pentacovalent phosphorus, and the long lived, noncovalent ternary complex Pgp⅐MgADP⅐Vi is analogous to the catalytic transition state, Pgp⅐MgADP⅐P i (18,34,35 Fig.…”
Section: The Mutant Pgp E556q/e1201q Exhibits Very Low Levels Of Atp mentioning
confidence: 99%
“…The Pgps were incubated with increasing concentrations of 8-azido-[␣- 32 sis allow the nucleotide diphosphate to be occluded in the presence of Vi (3,18). Vi mimics the pentacovalent phosphorus, and the long lived, noncovalent ternary complex Pgp⅐MgADP⅐Vi is analogous to the catalytic transition state, Pgp⅐MgADP⅐P i (18,34,35 Fig. 2A shows that both wild-type and the E556Q/E1201Q mutant Pgps have comparable affinities (11.07 Ϯ 0.4 M and 10.7 Ϯ 0.28 M, respectively).…”
Section: The Mutant Pgp E556q/e1201q Exhibits Very Low Levels Of Atp mentioning
confidence: 99%
See 1 more Smart Citation
“…This change in CydD was sufficient to disrupt function, as assessed by failure to restore growth of a cydD mutant under selective conditions and total lack of cytochrome d spectral signals (not shown). P-glycoprotein (the multidrug-resistance protein) indicate that the two ATP-binding sites cannot function independently and a strong cooperative interaction occurs between the two (Urbatsch et al, 1995). The requirement for two ABC domains in CydDC is demonstrated by the fact that the directed G388K/K389Q mutation of CydD in the nucleotide-binding domain disrupts function.…”
mentioning
confidence: 99%